Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mudit Mishra

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Pharmaceutics

Biomedicines

International journal of molecular sciences

ASAIO journal (American Society for Artificial Internal Organs : 1992)

UMC Utrecht

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UMC Utrecht

Netherlands

Postdoctoral Fellow :: Department of Cardiology

Publications

Selma E Kaffka Genaamd Dengler, Mudit Mishra, Sjoerd van Tuijl, Saskia C A de Jager, Joost P G Sluijter, Pieter A M Doevendans, Niels P van der Kaaij
Cold Oxygenated Machine Perfusion Improves Functional Survival of Slaughterhouse Porcine Hearts. ASAIO journal (American Society for Artificial Internal Organs : 1992) (2023)
Selma E Kaffka Genaamd Dengler, Mudit Mishra, Mats T Vervoorn, Jord Kernkamp, Sjoerd van Tuijl, Saskia C A de Jager, Joost P G Sluijter, Pieter A M Doevendans, Niels P van der Kaaij
Hemofiltration Improves Blood Perfusate Conditions Leading to Improved Ex Situ Heart Perfusion. ASAIO journal (American Society for Artificial Internal Organs : 1992) (2023)
Luxi Ji, Mudit Mishra, Bart De Geest
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials. Pharmaceutics 15 (4) (2023)
Luxi Ji, Mudit Mishra, Bart De Geest
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials. Pharmaceutics 15 (4) (2023)
Bart De Geest, Mudit Mishra
The metabolic syndrome in obese and non-obese subjects: a reappraisal of the syndrome X of Reaven. European journal of preventive cardiology (2023)
Luxi Ji, Mudit Mishra, Bart De Geest
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials. Pharmaceutics 15 (4) (2023)
Luxi Ji, Mudit Mishra, Bart De Geest
The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials. Pharmaceutics 15 (4) (2023)
Bart De Geest, Mudit Mishra
New Perspectives on Cholesterol and Lipoprotein Metabolism. International journal of molecular sciences 24 (14) (2023)
Ilayaraja Muthuramu, Mudit Mishra, Bart De Geest
Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure. Biomedicines 10 (7) (2022)
Bart De Geest, Mudit Mishra
Impact of High-Density Lipoproteins on Sepsis. International journal of molecular sciences 23 (21) (2022)
Bart De Geest, Mudit Mishra
Role of Oxidative Stress in Diabetic Cardiomyopathy. Antioxidants (Basel, Switzerland) 11 (4) (2022)
Bart De Geest, Mudit Mishra
Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies. Biomedicines 9 (11) (2021)
Mudit Mishra, Bart De Geest
High-Density Lipoprotein-Targeted Therapies for Heart Failure. Biomedicines 8 (12) (2020)
Joseph-Pierre Aboumsallem, Ilayaraja Muthuramu, Mudit Mishra, Herman J Kempen, Bart De Geest
Effective Treatment of Diabetic Cardiomyopathy and Heart Failure with Reconstituted HDL (Milano) in Mice. International journal of molecular sciences 20 (6) (2019)

Mudit Mishra.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mudit Mishra